Media Center

Prix Galien USA 2026 laureates announced

The twentieth edition of the Prix Galien USA Awards took place on 29 October at the American Museum of Natural History in New York.

Photo: Prix Galien

The Galien Foundation has announced the 2026 Prix Galien USA laureates. The twentieth edition of the US awards took place on 29 October at the American Museum of Natural History in New York. Expert committees, whose members included Nobel laureates, recognised achievements in pharmaceuticals, biotechnology, medical technology and digital health, alongside initiatives supporting innovation. The 2026 Prix Galien USA laureates: • Novartis - Best Pharmaceutical Product. • Denali Therapeutics - Best Biotechnology Product. • Syndax Pharmaceuticals - Best Product for Rare/Orphan Diseases. • Guardant Health - Best Medical Technology. • AEYE Health - Best Digital Health Solution. • PureTech Health - Incubators, Accelerators and Equity. • California Resources Corporation / Carbon TerraVault - Best EcoHealth Solution. • Strand Therapeutics - Best Startup, Biotechnology. • Science Corporation - Best Startup, Medical Technology / Digital Health. The inaugural Prix Galien Patient First Awards recognised Bristol Myers Squibb for its PEER programme and Cure HHT for “Nothing About HHT Without Us”. The ceremony also honoured the Prix Galien International recipients. The Polish edition of Prix Galien is part of a global tradition of recognising groundbreaking innovation in medicine and pharmacy. Further information about the laureates and award-winning innovations is available on The Galien Foundation's official website: https://www.galienfoundation.org/prix-galien-usa

More information

media@prixgaliencee.com

Stay up to date

Receive updates about Prix Galien Poland, Galien Forum and innovations in medicine.

Enter your email address to subscribe to our newsletter.